Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Batavia Bioservices Opens U.S. Lab | Contract Pharma

What are you searching for?

Sign in
Breaking News

Batavia Bioservices Opens U.S. Lab

Joins biotech hub in greater Boston area

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Batavia Bioservices, headquarted in Leiden, The Netherlands, will launch a U.S. lab facility in Woburn, MA. Batavia provides DNA cloning to Phase I/II manufacturing for all major classes of biopharmaceuticals, including antibodies, proteins and vaccines.
 
The 5,500-sq.-ft. facility contains multiple BSL-2 labs dedicated to molecular biology, mammalian cell line generation, protein production and purification, and assay development. The company has hired six employees for the new facility, with plans to hire four more. 
 
Menzo Havenga, president and chief executive officer of Batavia, said, “We have been growing more than 400% in the past two years in the Netherlands and to keep up with customer demand we have decided to launch a facility in the Boston area.”
 
Christopher Yallop, chief operating officer, added, “We have chosen the greater Boston area due to its importance as a biotech cluster. Positioning ourselves here allows us to be close to our customers, which we deem extremely important in delivering on time and on budget.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters